Intensity and focus of heart failure disease management after hospital discharge

Although features of heart failure disease management programs are broadly outlined, little is known about which interventions are actually used in the outpatient setting or which patients are most likely to require interventions. Between September 2001 and June 2002, we enrolled 32 patients admitte...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American heart journal 2005-04, Vol.149 (4), p.715-721
Hauptverfasser: Shah, Monica R., Flavell, Carol M., Weintraub, Joanne R., Young, Michelle A., Hasselblad, Vic, Fang, James C., Nohria, Anju, Lewis, Eldrin F., Givertz, Michael M., Mudge, Gilbert, Stevenson, Lynne W.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 721
container_issue 4
container_start_page 715
container_title The American heart journal
container_volume 149
creator Shah, Monica R.
Flavell, Carol M.
Weintraub, Joanne R.
Young, Michelle A.
Hasselblad, Vic
Fang, James C.
Nohria, Anju
Lewis, Eldrin F.
Givertz, Michael M.
Mudge, Gilbert
Stevenson, Lynne W.
description Although features of heart failure disease management programs are broadly outlined, little is known about which interventions are actually used in the outpatient setting or which patients are most likely to require interventions. Between September 2001 and June 2002, we enrolled 32 patients admitted to the Brigham and Women's Hospital Heart Failure Services, Boston, Mass, with decompensated heart failure. The intensity of care and outcomes of these patients were prospectively tracked for more than 90 days. During this time, there were 325 patient contacts (median 8.5 per patient), including 247 calls (median 7 per patient) and 78 clinic visits (median 2 per patient). Brigham and Women's Hospital clinicians adjusted diuretics a total of 109 times (median 2.5 times per patient). When frequency of diuretic adjustments was used to estimate the intensity of care, higher values of blood urea nitrogen at discharge predicted an increased intensity of care during the 90-day follow-up (relative risk [RR] 1.2, 95% confidence interval [CI] 1.0-1.3, P = .02). When frequency of clinic visits, telephone calls, and diuretic adjustments were used to estimate intensity of care, discharge creatinine (RR 1.03, 95% CI 0.99-1.06, P = .05), discharge blood urea nitrogen (RR 1.13, 95% CI 1.04-1.23, P = .004), and length of stay (RR 1.07, 95% CI 1.00-1.13, P = .04) were predictors of the composite end point. Even after undergoing optimization of medications during admission for acute heart failure, patients in a comprehensive disease management program required frequent interventions to maintain clinical stability. Renal dysfunction was the strongest predictor of increased interventions and worse outcome.
doi_str_mv 10.1016/j.ahj.2004.11.020
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67991077</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002870304008725</els_id><sourcerecordid>67991077</sourcerecordid><originalsourceid>FETCH-LOGICAL-c409t-ced591d583a515cb0e770a204cf4d5b18d562f11199d979d0eb5f6bdb1990dae3</originalsourceid><addsrcrecordid>eNp9kU2LFDEQhoMo7rj6A7xIg-it26qeTqeDJ1n8WFjQg55DdVLZSdMfY9It7L83wwwsePBUpHiq6uWJEK8RKgRsPwwVHYaqBmgqxApqeCJ2CFqVrWqap2IHAHXZKdhfiRcpDfnZ1l37XFyh1BqU7Hbix-288pzC-lDQ7Aq_2C0Viy8OTHEtPIVxi1y4kJgSFxPNdM8Tz2tBfuVYHJZ0DCuNJ8IeKN7zS_HM05j41aVei19fPv-8-Vbeff96e_PprrQN6LW07KRGJ7s9SZS2B1YKqIbG-sbJHjsn29ojotZOK-2Ae-nb3vW5AY54fy3en_ce4_J747SaKUfgcaSZly2ZVmmNoFQG3_4DDssW55zNoISmaVS-mik8UzYuKUX25hjDRPHBIJiTbDOYLNucZBtEk2XnmTeXzVs_sXucuNjNwLsLQMnS6CPNNqRHLn8T4P50_OOZ4yzsT-Bokg08Z0chsl2NW8J_YvwFC1-b4A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1504447204</pqid></control><display><type>article</type><title>Intensity and focus of heart failure disease management after hospital discharge</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Shah, Monica R. ; Flavell, Carol M. ; Weintraub, Joanne R. ; Young, Michelle A. ; Hasselblad, Vic ; Fang, James C. ; Nohria, Anju ; Lewis, Eldrin F. ; Givertz, Michael M. ; Mudge, Gilbert ; Stevenson, Lynne W.</creator><creatorcontrib>Shah, Monica R. ; Flavell, Carol M. ; Weintraub, Joanne R. ; Young, Michelle A. ; Hasselblad, Vic ; Fang, James C. ; Nohria, Anju ; Lewis, Eldrin F. ; Givertz, Michael M. ; Mudge, Gilbert ; Stevenson, Lynne W.</creatorcontrib><description>Although features of heart failure disease management programs are broadly outlined, little is known about which interventions are actually used in the outpatient setting or which patients are most likely to require interventions. Between September 2001 and June 2002, we enrolled 32 patients admitted to the Brigham and Women's Hospital Heart Failure Services, Boston, Mass, with decompensated heart failure. The intensity of care and outcomes of these patients were prospectively tracked for more than 90 days. During this time, there were 325 patient contacts (median 8.5 per patient), including 247 calls (median 7 per patient) and 78 clinic visits (median 2 per patient). Brigham and Women's Hospital clinicians adjusted diuretics a total of 109 times (median 2.5 times per patient). When frequency of diuretic adjustments was used to estimate the intensity of care, higher values of blood urea nitrogen at discharge predicted an increased intensity of care during the 90-day follow-up (relative risk [RR] 1.2, 95% confidence interval [CI] 1.0-1.3, P = .02). When frequency of clinic visits, telephone calls, and diuretic adjustments were used to estimate intensity of care, discharge creatinine (RR 1.03, 95% CI 0.99-1.06, P = .05), discharge blood urea nitrogen (RR 1.13, 95% CI 1.04-1.23, P = .004), and length of stay (RR 1.07, 95% CI 1.00-1.13, P = .04) were predictors of the composite end point. Even after undergoing optimization of medications during admission for acute heart failure, patients in a comprehensive disease management program required frequent interventions to maintain clinical stability. Renal dysfunction was the strongest predictor of increased interventions and worse outcome.</description><identifier>ISSN: 0002-8703</identifier><identifier>EISSN: 1097-6744</identifier><identifier>DOI: 10.1016/j.ahj.2004.11.020</identifier><identifier>PMID: 15990758</identifier><identifier>CODEN: AHJOA2</identifier><language>eng</language><publisher>New York, NY: Mosby, Inc</publisher><subject><![CDATA[Adrenergic beta-Antagonists - administration & dosage ; Adrenergic beta-Antagonists - therapeutic use ; Adult ; Age ; Aged ; Ambulatory Care - statistics & numerical data ; Angiotensin-Converting Enzyme Inhibitors - administration & dosage ; Angiotensin-Converting Enzyme Inhibitors - therapeutic use ; Biological and medical sciences ; Blood Urea Nitrogen ; Cardiology. Vascular system ; Case Management - statistics & numerical data ; Creatinine - blood ; Disease management ; Diuretics - administration & dosage ; Diuretics - therapeutic use ; Drug therapy ; Drug Therapy, Combination ; Female ; Follow-Up Studies ; Heart ; Heart failure ; Heart Failure - complications ; Heart Failure - drug therapy ; Heart Failure - metabolism ; Heart Failure - nursing ; Heart Failure - therapy ; Heart failure, cardiogenic pulmonary edema, cardiac enlargement ; Heart rate ; Heart Transplantation - statistics & numerical data ; Hemodynamics ; Hospitalization ; Hospitalization - statistics & numerical data ; Humans ; Kidney Diseases - complications ; Kidney Diseases - urine ; Male ; Medical prognosis ; Medical sciences ; Middle Aged ; Nurses ; Office Visits - statistics & numerical data ; Patients ; Prospective Studies ; Risk Factors ; Stroke Volume ; Telephone - statistics & numerical data ; Variables ; Vasodilator Agents - administration & dosage ; Vasodilator Agents - therapeutic use ; Water-Electrolyte Imbalance - drug therapy ; Water-Electrolyte Imbalance - etiology]]></subject><ispartof>The American heart journal, 2005-04, Vol.149 (4), p.715-721</ispartof><rights>2005</rights><rights>2005 INIST-CNRS</rights><rights>Copyright Elsevier Limited Apr 2005</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c409t-ced591d583a515cb0e770a204cf4d5b18d562f11199d979d0eb5f6bdb1990dae3</citedby><cites>FETCH-LOGICAL-c409t-ced591d583a515cb0e770a204cf4d5b18d562f11199d979d0eb5f6bdb1990dae3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0002870304008725$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16740134$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15990758$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shah, Monica R.</creatorcontrib><creatorcontrib>Flavell, Carol M.</creatorcontrib><creatorcontrib>Weintraub, Joanne R.</creatorcontrib><creatorcontrib>Young, Michelle A.</creatorcontrib><creatorcontrib>Hasselblad, Vic</creatorcontrib><creatorcontrib>Fang, James C.</creatorcontrib><creatorcontrib>Nohria, Anju</creatorcontrib><creatorcontrib>Lewis, Eldrin F.</creatorcontrib><creatorcontrib>Givertz, Michael M.</creatorcontrib><creatorcontrib>Mudge, Gilbert</creatorcontrib><creatorcontrib>Stevenson, Lynne W.</creatorcontrib><title>Intensity and focus of heart failure disease management after hospital discharge</title><title>The American heart journal</title><addtitle>Am Heart J</addtitle><description>Although features of heart failure disease management programs are broadly outlined, little is known about which interventions are actually used in the outpatient setting or which patients are most likely to require interventions. Between September 2001 and June 2002, we enrolled 32 patients admitted to the Brigham and Women's Hospital Heart Failure Services, Boston, Mass, with decompensated heart failure. The intensity of care and outcomes of these patients were prospectively tracked for more than 90 days. During this time, there were 325 patient contacts (median 8.5 per patient), including 247 calls (median 7 per patient) and 78 clinic visits (median 2 per patient). Brigham and Women's Hospital clinicians adjusted diuretics a total of 109 times (median 2.5 times per patient). When frequency of diuretic adjustments was used to estimate the intensity of care, higher values of blood urea nitrogen at discharge predicted an increased intensity of care during the 90-day follow-up (relative risk [RR] 1.2, 95% confidence interval [CI] 1.0-1.3, P = .02). When frequency of clinic visits, telephone calls, and diuretic adjustments were used to estimate intensity of care, discharge creatinine (RR 1.03, 95% CI 0.99-1.06, P = .05), discharge blood urea nitrogen (RR 1.13, 95% CI 1.04-1.23, P = .004), and length of stay (RR 1.07, 95% CI 1.00-1.13, P = .04) were predictors of the composite end point. Even after undergoing optimization of medications during admission for acute heart failure, patients in a comprehensive disease management program required frequent interventions to maintain clinical stability. Renal dysfunction was the strongest predictor of increased interventions and worse outcome.</description><subject>Adrenergic beta-Antagonists - administration &amp; dosage</subject><subject>Adrenergic beta-Antagonists - therapeutic use</subject><subject>Adult</subject><subject>Age</subject><subject>Aged</subject><subject>Ambulatory Care - statistics &amp; numerical data</subject><subject>Angiotensin-Converting Enzyme Inhibitors - administration &amp; dosage</subject><subject>Angiotensin-Converting Enzyme Inhibitors - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Blood Urea Nitrogen</subject><subject>Cardiology. Vascular system</subject><subject>Case Management - statistics &amp; numerical data</subject><subject>Creatinine - blood</subject><subject>Disease management</subject><subject>Diuretics - administration &amp; dosage</subject><subject>Diuretics - therapeutic use</subject><subject>Drug therapy</subject><subject>Drug Therapy, Combination</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Heart</subject><subject>Heart failure</subject><subject>Heart Failure - complications</subject><subject>Heart Failure - drug therapy</subject><subject>Heart Failure - metabolism</subject><subject>Heart Failure - nursing</subject><subject>Heart Failure - therapy</subject><subject>Heart failure, cardiogenic pulmonary edema, cardiac enlargement</subject><subject>Heart rate</subject><subject>Heart Transplantation - statistics &amp; numerical data</subject><subject>Hemodynamics</subject><subject>Hospitalization</subject><subject>Hospitalization - statistics &amp; numerical data</subject><subject>Humans</subject><subject>Kidney Diseases - complications</subject><subject>Kidney Diseases - urine</subject><subject>Male</subject><subject>Medical prognosis</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Nurses</subject><subject>Office Visits - statistics &amp; numerical data</subject><subject>Patients</subject><subject>Prospective Studies</subject><subject>Risk Factors</subject><subject>Stroke Volume</subject><subject>Telephone - statistics &amp; numerical data</subject><subject>Variables</subject><subject>Vasodilator Agents - administration &amp; dosage</subject><subject>Vasodilator Agents - therapeutic use</subject><subject>Water-Electrolyte Imbalance - drug therapy</subject><subject>Water-Electrolyte Imbalance - etiology</subject><issn>0002-8703</issn><issn>1097-6744</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kU2LFDEQhoMo7rj6A7xIg-it26qeTqeDJ1n8WFjQg55DdVLZSdMfY9It7L83wwwsePBUpHiq6uWJEK8RKgRsPwwVHYaqBmgqxApqeCJ2CFqVrWqap2IHAHXZKdhfiRcpDfnZ1l37XFyh1BqU7Hbix-288pzC-lDQ7Aq_2C0Viy8OTHEtPIVxi1y4kJgSFxPNdM8Tz2tBfuVYHJZ0DCuNJ8IeKN7zS_HM05j41aVei19fPv-8-Vbeff96e_PprrQN6LW07KRGJ7s9SZS2B1YKqIbG-sbJHjsn29ojotZOK-2Ae-nb3vW5AY54fy3en_ce4_J747SaKUfgcaSZly2ZVmmNoFQG3_4DDssW55zNoISmaVS-mik8UzYuKUX25hjDRPHBIJiTbDOYLNucZBtEk2XnmTeXzVs_sXucuNjNwLsLQMnS6CPNNqRHLn8T4P50_OOZ4yzsT-Bokg08Z0chsl2NW8J_YvwFC1-b4A</recordid><startdate>20050401</startdate><enddate>20050401</enddate><creator>Shah, Monica R.</creator><creator>Flavell, Carol M.</creator><creator>Weintraub, Joanne R.</creator><creator>Young, Michelle A.</creator><creator>Hasselblad, Vic</creator><creator>Fang, James C.</creator><creator>Nohria, Anju</creator><creator>Lewis, Eldrin F.</creator><creator>Givertz, Michael M.</creator><creator>Mudge, Gilbert</creator><creator>Stevenson, Lynne W.</creator><general>Mosby, Inc</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20050401</creationdate><title>Intensity and focus of heart failure disease management after hospital discharge</title><author>Shah, Monica R. ; Flavell, Carol M. ; Weintraub, Joanne R. ; Young, Michelle A. ; Hasselblad, Vic ; Fang, James C. ; Nohria, Anju ; Lewis, Eldrin F. ; Givertz, Michael M. ; Mudge, Gilbert ; Stevenson, Lynne W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c409t-ced591d583a515cb0e770a204cf4d5b18d562f11199d979d0eb5f6bdb1990dae3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adrenergic beta-Antagonists - administration &amp; dosage</topic><topic>Adrenergic beta-Antagonists - therapeutic use</topic><topic>Adult</topic><topic>Age</topic><topic>Aged</topic><topic>Ambulatory Care - statistics &amp; numerical data</topic><topic>Angiotensin-Converting Enzyme Inhibitors - administration &amp; dosage</topic><topic>Angiotensin-Converting Enzyme Inhibitors - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Blood Urea Nitrogen</topic><topic>Cardiology. Vascular system</topic><topic>Case Management - statistics &amp; numerical data</topic><topic>Creatinine - blood</topic><topic>Disease management</topic><topic>Diuretics - administration &amp; dosage</topic><topic>Diuretics - therapeutic use</topic><topic>Drug therapy</topic><topic>Drug Therapy, Combination</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Heart</topic><topic>Heart failure</topic><topic>Heart Failure - complications</topic><topic>Heart Failure - drug therapy</topic><topic>Heart Failure - metabolism</topic><topic>Heart Failure - nursing</topic><topic>Heart Failure - therapy</topic><topic>Heart failure, cardiogenic pulmonary edema, cardiac enlargement</topic><topic>Heart rate</topic><topic>Heart Transplantation - statistics &amp; numerical data</topic><topic>Hemodynamics</topic><topic>Hospitalization</topic><topic>Hospitalization - statistics &amp; numerical data</topic><topic>Humans</topic><topic>Kidney Diseases - complications</topic><topic>Kidney Diseases - urine</topic><topic>Male</topic><topic>Medical prognosis</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Nurses</topic><topic>Office Visits - statistics &amp; numerical data</topic><topic>Patients</topic><topic>Prospective Studies</topic><topic>Risk Factors</topic><topic>Stroke Volume</topic><topic>Telephone - statistics &amp; numerical data</topic><topic>Variables</topic><topic>Vasodilator Agents - administration &amp; dosage</topic><topic>Vasodilator Agents - therapeutic use</topic><topic>Water-Electrolyte Imbalance - drug therapy</topic><topic>Water-Electrolyte Imbalance - etiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shah, Monica R.</creatorcontrib><creatorcontrib>Flavell, Carol M.</creatorcontrib><creatorcontrib>Weintraub, Joanne R.</creatorcontrib><creatorcontrib>Young, Michelle A.</creatorcontrib><creatorcontrib>Hasselblad, Vic</creatorcontrib><creatorcontrib>Fang, James C.</creatorcontrib><creatorcontrib>Nohria, Anju</creatorcontrib><creatorcontrib>Lewis, Eldrin F.</creatorcontrib><creatorcontrib>Givertz, Michael M.</creatorcontrib><creatorcontrib>Mudge, Gilbert</creatorcontrib><creatorcontrib>Stevenson, Lynne W.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Physical Education Index</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The American heart journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shah, Monica R.</au><au>Flavell, Carol M.</au><au>Weintraub, Joanne R.</au><au>Young, Michelle A.</au><au>Hasselblad, Vic</au><au>Fang, James C.</au><au>Nohria, Anju</au><au>Lewis, Eldrin F.</au><au>Givertz, Michael M.</au><au>Mudge, Gilbert</au><au>Stevenson, Lynne W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Intensity and focus of heart failure disease management after hospital discharge</atitle><jtitle>The American heart journal</jtitle><addtitle>Am Heart J</addtitle><date>2005-04-01</date><risdate>2005</risdate><volume>149</volume><issue>4</issue><spage>715</spage><epage>721</epage><pages>715-721</pages><issn>0002-8703</issn><eissn>1097-6744</eissn><coden>AHJOA2</coden><abstract>Although features of heart failure disease management programs are broadly outlined, little is known about which interventions are actually used in the outpatient setting or which patients are most likely to require interventions. Between September 2001 and June 2002, we enrolled 32 patients admitted to the Brigham and Women's Hospital Heart Failure Services, Boston, Mass, with decompensated heart failure. The intensity of care and outcomes of these patients were prospectively tracked for more than 90 days. During this time, there were 325 patient contacts (median 8.5 per patient), including 247 calls (median 7 per patient) and 78 clinic visits (median 2 per patient). Brigham and Women's Hospital clinicians adjusted diuretics a total of 109 times (median 2.5 times per patient). When frequency of diuretic adjustments was used to estimate the intensity of care, higher values of blood urea nitrogen at discharge predicted an increased intensity of care during the 90-day follow-up (relative risk [RR] 1.2, 95% confidence interval [CI] 1.0-1.3, P = .02). When frequency of clinic visits, telephone calls, and diuretic adjustments were used to estimate intensity of care, discharge creatinine (RR 1.03, 95% CI 0.99-1.06, P = .05), discharge blood urea nitrogen (RR 1.13, 95% CI 1.04-1.23, P = .004), and length of stay (RR 1.07, 95% CI 1.00-1.13, P = .04) were predictors of the composite end point. Even after undergoing optimization of medications during admission for acute heart failure, patients in a comprehensive disease management program required frequent interventions to maintain clinical stability. Renal dysfunction was the strongest predictor of increased interventions and worse outcome.</abstract><cop>New York, NY</cop><pub>Mosby, Inc</pub><pmid>15990758</pmid><doi>10.1016/j.ahj.2004.11.020</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0002-8703
ispartof The American heart journal, 2005-04, Vol.149 (4), p.715-721
issn 0002-8703
1097-6744
language eng
recordid cdi_proquest_miscellaneous_67991077
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adrenergic beta-Antagonists - administration & dosage
Adrenergic beta-Antagonists - therapeutic use
Adult
Age
Aged
Ambulatory Care - statistics & numerical data
Angiotensin-Converting Enzyme Inhibitors - administration & dosage
Angiotensin-Converting Enzyme Inhibitors - therapeutic use
Biological and medical sciences
Blood Urea Nitrogen
Cardiology. Vascular system
Case Management - statistics & numerical data
Creatinine - blood
Disease management
Diuretics - administration & dosage
Diuretics - therapeutic use
Drug therapy
Drug Therapy, Combination
Female
Follow-Up Studies
Heart
Heart failure
Heart Failure - complications
Heart Failure - drug therapy
Heart Failure - metabolism
Heart Failure - nursing
Heart Failure - therapy
Heart failure, cardiogenic pulmonary edema, cardiac enlargement
Heart rate
Heart Transplantation - statistics & numerical data
Hemodynamics
Hospitalization
Hospitalization - statistics & numerical data
Humans
Kidney Diseases - complications
Kidney Diseases - urine
Male
Medical prognosis
Medical sciences
Middle Aged
Nurses
Office Visits - statistics & numerical data
Patients
Prospective Studies
Risk Factors
Stroke Volume
Telephone - statistics & numerical data
Variables
Vasodilator Agents - administration & dosage
Vasodilator Agents - therapeutic use
Water-Electrolyte Imbalance - drug therapy
Water-Electrolyte Imbalance - etiology
title Intensity and focus of heart failure disease management after hospital discharge
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T23%3A05%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Intensity%20and%20focus%20of%20heart%20failure%20disease%20management%20after%20hospital%20discharge&rft.jtitle=The%20American%20heart%20journal&rft.au=Shah,%20Monica%20R.&rft.date=2005-04-01&rft.volume=149&rft.issue=4&rft.spage=715&rft.epage=721&rft.pages=715-721&rft.issn=0002-8703&rft.eissn=1097-6744&rft.coden=AHJOA2&rft_id=info:doi/10.1016/j.ahj.2004.11.020&rft_dat=%3Cproquest_cross%3E67991077%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1504447204&rft_id=info:pmid/15990758&rft_els_id=S0002870304008725&rfr_iscdi=true